amantadine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 7 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aimed to develop and analyse poly(DL-lactic acid)-methacrylic acid nanospheres bound to the chelating ligand diethylenetriaminepentaacetic acid (DTPA) for the targeted delivery of amantadine in Amyotrophic Lateral Sclerosis (ALS)." | 7.88 | Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. ( Choonara, YE; Du Toit, LC; Govender, M; Indermun, S; Kumar, P; Mazibuko, Z; Modi, G; Naidoo, D; Pillay, V, 2018) |
| "This study aimed to develop and analyse poly(DL-lactic acid)-methacrylic acid nanospheres bound to the chelating ligand diethylenetriaminepentaacetic acid (DTPA) for the targeted delivery of amantadine in Amyotrophic Lateral Sclerosis (ALS)." | 3.88 | Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. ( Choonara, YE; Du Toit, LC; Govender, M; Indermun, S; Kumar, P; Mazibuko, Z; Modi, G; Naidoo, D; Pillay, V, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lapshina, MA | 1 |
| Shevtsova, EF | 1 |
| Grigoriev, VV | 1 |
| Aksinenko, AY | 1 |
| Ustyugov, AA | 1 |
| Steinberg, DA | 1 |
| Maleev, GV | 1 |
| Dubrovskaya, ES | 1 |
| Goreva, TV | 1 |
| Epishina, TA | 1 |
| Zamoyski, VL | 1 |
| Makhaeva, GF | 1 |
| Fisenko, VP | 1 |
| Veselov, IM | 1 |
| Vinogradova, DV | 1 |
| Bachurin, SO | 1 |
| Zhang, D | 1 |
| Geng, H | 1 |
| Cao, L | 1 |
| Li, W | 1 |
| Mazibuko, Z | 1 |
| Indermun, S | 1 |
| Govender, M | 1 |
| Kumar, P | 1 |
| Du Toit, LC | 1 |
| Choonara, YE | 1 |
| Modi, G | 1 |
| Naidoo, D | 1 |
| Pillay, V | 1 |
| Iwasaki, Y | 1 |
| Iguchi, H | 1 |
| Ichikawa, Y | 1 |
| Igarashi, O | 1 |
| Kawabe, S | 1 |
| Kiyozuka, T | 1 |
| Maruyama, M | 1 |
| Ikeda, K | 1 |
| Fujioka, T | 1 |
| Munsat, TL | 1 |
| Easterday, CS | 1 |
| Levy, S | 1 |
| Wolff, SM | 1 |
| Hiatt, R | 1 |
| Norris, FH | 1 |
| Brait, K | 1 |
| Fahn, S | 1 |
| Schwarz, GA | 1 |
1 trial available for amantadine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Amantadine and guanidine are ineffective in ALS.
Topics: Amantadine; Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Double-Blind Method; Guanidines | 1981 |
6 other studies available for amantadine and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments.
Topics: Adamantane; Amantadine; Amyotrophic Lateral Sclerosis; Edaravone; Humans; Neuroprotective Agents; Ri | 2023 |
Clinical and Electrophysiological Features of Chronic Motor Axonal Neuropathy.
Topics: Amantadine; Amyotrophic Lateral Sclerosis; Electrophysiological Phenomena; Humans; Motor Neurons; Mu | 2022 |
Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis.
Topics: Amantadine; Amyotrophic Lateral Sclerosis; Animals; Antiparkinson Agents; Cells, Cultured; Drug Deli | 2018 |
Fatigue and depression are associated with poor quality of life in ALS.
Topics: Adaptation, Psychological; Amantadine; Amyotrophic Lateral Sclerosis; Caregivers; Cross-Sectional St | 2003 |
Amantadine in Jakob-Creutzfeldt disease.
Topics: Amantadine; Amyotrophic Lateral Sclerosis; Central Nervous System Diseases; Creutzfeldt-Jakob Syndro | 1972 |
Sporadic and familial parkinsonism and motor neuron disease.
Topics: Aged; Amantadine; Amyotrophic Lateral Sclerosis; Cerebellar Diseases; Corpus Striatum; Dihydroxyphen | 1973 |